Reach - a non-regulatory announcement
26 November 2021
Braveheart Investment Group plc
("Braveheart" or the "Group")
Video from The University of Sheffield re Paraytec
Braveheart Investment Group (AIM: BRH) announces that, the Group has been advised that The University of Sheffield has produced a brief video regarding the work it has been doing with Paraytec which is available to view at https://www.sheffield.ac.uk/news/university-sheffield-researchers-develop-quicker-more-accurate-covid-test and via the Group's website at www.braveheartgroup.co.uk
For further information:
| |
Braveheart Investment Group plc | Tel: 01738 587555 |
Trevor Brown CEO | |
| |
Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
David Worlidge / James Reeve / George Payne | |
| |
Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
Heena Karani / Lucy Williams | |
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.